Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Total Liabilities (2023 - 2026)

Adagio Medical Holdings has reported Total Liabilities over the past 4 years, most recently at $33.6 million for Q1 2026.

  • Quarterly Total Liabilities rose 16.05% to $33.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $33.6 million through Mar 2026, up 16.05% year-over-year, with the annual reading at $30.9 million for FY2025, 8.11% up from the prior year.
  • Total Liabilities was $33.6 million for Q1 2026 at Adagio Medical Holdings, up from $30.9 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $139.2 million in Q1 2024 and troughed at $5000.0 in Q2 2024.
  • The 4-year median for Total Liabilities is $30.9 million (2025), against an average of $47.5 million.
  • The largest YoY upside for Total Liabilities was 544100.0% in 2025 against a maximum downside of 79.21% in 2025.
  • A 4-year view of Total Liabilities shows it stood at $47.4 million in 2023, then plummeted by 39.77% to $28.5 million in 2024, then increased by 8.11% to $30.9 million in 2025, then increased by 8.86% to $33.6 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Total Liabilities are $33.6 million (Q1 2026), $30.9 million (Q4 2025), and $32.9 million (Q3 2025).